Skip to Content
Merck

A ligand-based system for receptor-specific delivery of proteins.

Scientific reports (2019-12-18)
Mariano Maffei, Chiara Morelli, Ellie Graham, Stefano Patriarca, Laura Donzelli, Balint Doleschall, Fernanda de Castro Reis, Linda Nocchi, Cora H Chadick, Luc Reymond, Ivan R Corrêa, Kai Johnsson, Jamie A Hackett, Paul A Heppenstall
ABSTRACT

Gene delivery using vector or viral-based methods is often limited by technical and safety barriers. A promising alternative that circumvents these shortcomings is the direct delivery of proteins into cells. Here we introduce a non-viral, ligand-mediated protein delivery system capable of selectively targeting primary skin cells in-vivo. Using orthologous self-labelling tags and chemical cross-linkers, we conjugate large proteins to ligands that bind their natural receptors on the surface of keratinocytes. Targeted CRE-mediated recombination was achieved by delivery of ligand cross-linked CRE protein to the skin of transgenic reporter mice, but was absent in mice lacking the ligand's cell surface receptor. We further show that ligands mediate the intracellular delivery of Cas9 allowing for CRISPR-mediated gene editing in the skin more efficiently than adeno-associated viral gene delivery. Thus, a ligand-based system enables the effective and receptor-specific delivery of large proteins and may be applied to the treatment of skin-related genetic diseases.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
TAT-CRE Recombinase, TAT-CRE Recombinase is a recombinant cell-permeant fusion cre-recombinase protein consisting of TAT sequence, a nuclear localization sequence (NLS) and it is known to catalyze the site specific recombination event between two loxP DNA sites.
Sigma-Aldrich
RIPA Buffer
Sigma-Aldrich
Dispase® II, protease
Sigma-Aldrich
Nitrilotriacetic acid disodium salt, Sigma Grade, ≥99%
Sigma-Aldrich
Rat Tail Collagen Coating Solution (20 ML), Type I, 50 μg/mL, solution, BioReagent, suitable for cell culture